课题基金 / 基金详情

CaPITTAL: Canadian Patient-oriented Immune Tolerance in Transplantation and Autoimmunity to improve Lives

CaPITTAL: Canadian Patient-oriented Immune Tolerance in Transplantation and Autoimmunity to improve Lives
CaPITTAL：加拿大以患者为导向的移植免疫耐受和自身免疫以改善生活
批准号：
323878
负责人：
Schultz Kirk R
金额：
$3.64万
依托单位：
University of British Columbia
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2015
资助国家：
加拿大
项目状态：
已结题
起止时间：
2015-01-01 至 2016-01-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=323878&lang=en
关键词：
Biomarkers Blood And Marrow Transplantation Economic Impact Of Health Care First In Human Clinical Trials Immune Tolerance Long Term Outcomes Multiple Sclerosis Patient Engagement Solid Organ Transplantation Type 1 Diabetes Mellitus

项目摘要

项目成果

Schultz Kirk R的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A functional immune system is essential for health. In a process called immune tolerance, it fends off dangerous foreign substances but leave the body's own tissues untouched. Failure of immune tolerance causes chronic autoimmune diseases (such as multipl
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulatory Natural Killer Cell Treatment in Chronic Graft-versus-Host Disease and Solid Organ Transplantation Chronic Rejection
  • 批准号：
    441672
  • 项目类别：
    Operating Grants
  • 资助金额：
    $54.64万
  • 财政年份：
    2021
  • 负责人：
    Schultz Kirk R
  • 依托单位：
    University of British Columbia
Correlative Studies to Improve Blood and Marrow Transplantation and Leukemia Immunotherapy in Children
Applying Biomarkers to Long-term Effects in Child and Adolescent Cancer Treatment (ABLE Team)
Applying Biomarkers to Long-term Effects in Child and Adolescent Cancer Treatment (ABLE Team)
海外基金